Cannabis News

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") today announced that Philip Young, CEO and Director, will present at the H.C. Wainwright 23rd Annual Global Investor Conference taking place Sept. 13-15, 2021.

The presentation will be available on demand through the H.C. Wainwright conference portal, beginning at 7:00 a.m. ET on Monday, Sept. 13, 2021.

Registration for the event is accessible via www.hcwevents.com/annualconference.

The Company will also participate in one-on-one meetings during the conference.

* * *

About Lobe Sciences Ltd.

Lobe Sciences is a life sciences company focused on psychedelic medicines. The Company, through collaborations with industry-leading partners, is engaged in drug research and development using psychedelic compounds and the development of innovative devices and delivery mechanisms to improve mental health and wellness.

For further information please contact:

Lobe Sciences Ltd.
Philip J Young, CEO
info@lobesciences.com
Tel: (949) 505-5623

THE CSE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

Disclaimer for Forward-Looking Statements

This news release contains forward-looking statements relating to the future operations of the Company and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact included in this release, including statements regarding the future plans and objectives of the Company, research and development using psychedelic compounds, and the development of innovative devices and delivery mechanisms to improve mental health and wellness, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Readers are cautioned that assumptions used in the preparation of the forward-looking statements may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, including changes to the regulatory environment;, that the Company's drug research and development activities may be unsuccessful; that drugs and medical devices produced by, or on behalf of, the Company, may not work in the manner intended or at all, and may subject the Company to product liability or other liability claims; that the Company may not be able to attain the Company's corporate goals and objectives; and other risk factors detailed in the Company's continuous disclosure filings from time to time, as available under the Company's profile at www.sedar.com. As a result, the Company cannot guarantee that any forward-looking statement will materialize and the reader is cautioned not to place undue reliance on any forward-looking information. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made only as of the date of this news release and the Company does not intend to update any of the included forward-looking statements except as expressly required by applicable Canadian securities laws.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/96037.

News Provided by Newsfile via QuoteMedia

Lobe Sciences

Lobe Sciences


Keep reading...Show less

TerrAscend Reduces Outstanding Debt by US$30 Million

Elects to pay down $30 million of its maturing $55 million senior secured Michigan loan, refinancing the remaining $25 million

TerrAscend Corp. ("TerrAscend" or the "Company") (CSE: TER) (OTCQX: TRSSF), a North American cannabis operator, today announced that its subsidiary, WDB Holding MI, Inc. (DE), and all subsidiaries of TerrAscend (collectively, the "Borrowers"), refinanced the existing senior secured term loan of $55.0 million previously announced on November 22, 2021 (the "Michigan Loan"), pursuant to an amendment (the "Amendment"). The Amendment provides for a senior secured term loan with a principal amount of $25.0 million plus incremental term loans of $30.0 million at the option of TerrAscend and subject to consents from the required lenders for an aggregate amount of $55.0 million . On November 29, 2022 the Borrowers repaid $55.0 million outstanding principal amount under the original Michigan Loan, using $30.0 million of cash on hand and $25.0 million through borrowing pursuant to the Amendment. Chicago Atlantic Admin, LLC serves as administrative agent for the lenders under the Michigan Loan and as collateral agent for the secured parties thereto.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Green Thumb Industries Announces Conference Participation for December 2022

Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries today announced its executive team will participate in the following conference in December 2022:

Cowen 5 th Annual Cannabis Conference (Virtual) , December 6, 2022 : Management will participate in one-on-one meetings and Ben Kovler, Green Thumb Founder, Chairman and Chief Executive Officer, will participate in a fireside chat with Vivien Azer, Managing Director and senior research analyst specializing in the beverages, tobacco, and cannabis sectors.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Cronos Group Inc. to Speak at Stifel Canada's 3rd Annual Future of Healthcare Conference

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company"), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and Chief Executive Officer, will speak at Stifel Canada's 3 rd Annual Future of Healthcare Conference on Wednesday, December 7, 2022 at 1:00 p.m. ET.

A webcast will be available on the Investors section of the Company's website at: https://ir.thecronosgroup.com/events-presentations .

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Good Green Announces its Third Round of Grant Recipients

Good Green a cannabis flower brand owned by Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), today announced the third group of nonprofit organizations to receive unrestricted funding as part of its grant program.

"Just over a year ago, Good Green was launched with the goal of creating opportunity within Black and Brown communities that have been disproportionately impacted by the War on Drugs," said Green Thumb Founder, Chairman and Chief Executive Officer Ben Kovler. "Since then, the grant program has funded a spectrum of meaningful, mission-driven initiatives to foster change and help repair cannabis-related injustices. We are honored to support four additional organizations in their efforts to rectify the wrongs of cannabis prohibition and uplift those negatively affected."

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
cannabis bud in pair of hands

Cannabis Weekly Round-Up: Connecticut Won’t See Adult Stores This Year

Connecticut may have to wait until the new year to see adult-use cannabis shops open, according to a new report.

Also this past week, new figures for recreational cannabis sales in Canada continue to showed growth year-over-year in the largest three markets in the space.

Keep reading to find out more cannabis highlights from the past five days.

Keep reading...Show less

Curaleaf Celebrates Opening of New Dispensaries in Orlando and Miami, FL

Company's retail presence now at 54 locations in Florida and 144 nationwide

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of two new Florida dispensaries, Orlando International Drive and Miami South Beach. The new locations are Curaleaf's 53 rd and 54 th locations to open in the Sunshine State and 144 th nationwide.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×